Inspection Questions Delay CBER’s Embrace Of Real-Time Oncology Review

 
• By Derrick Gingery
  
A scientist in sterile coverall gown pipetting medium or reagents for cell culture experiment in biological safety cabinet.
The complex biologic manufacturing process could limit the applicability of real-time review. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards